| Afinitor 5 mg, Tabletten - 30 | | 59174001 | | Novartis Pharma Schweiz AG | | Afinitor 5 mg, Tabletten | | 17.11.2009 | | Original | | 17.11.2009 | | Everolimus (L01XE10) | | | | WHO-DDD | | | | 70000. | | 30 | | 07.16.40. | | | | A | | | | Nein | | | | FI | | PI | | 1049.49 | | | | 10% | | 1144.90 | | FB | | | | 7680591740016 | | Biotechnologika | | | | |
| | Zusammensetzung | | everolimusum 5 mg, lactosum 143.75 mg, crospovidonum, hypromellosum, lactosum monohydricum 4.9 mg, magnesii stearas, E 321, pro compresso. | | Packungsbestandteile | | Tabletten | | | | | Wirkstoffe | Stärke |
|---|
| Everolimusum | 5 mg |
| | BAG: Wirkstoffe | Stärke |
|---|
| Everolimusum | 5 mg |
| | | | Hilfsstoffe | Stärke |
|---|
| Crospovidonum | | | E 321 | | | Hypromellosum | | | Lactosum | 143.75 mg | | Lactosum Monohydricum | 4.9 mg | | Magnesii Stearas | | | Pro Compresso | |
| |
| | Quelle | | | |
|
|
